These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35466932)

  • 21. Indeterminate solid hepatic lesions identified on non-diagnostic contrast-enhanced computed tomography: assessment of the additional diagnostic value of contrast-enhanced ultrasound in the non-cirrhotic liver.
    Quaia E; De Paoli L; Angileri R; Cabibbo B; Cova MA
    Eur J Radiol; 2014 Mar; 83(3):456-62. PubMed ID: 24387826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.
    Sawatzki M; Meyenberger C; Brand S; Semela D
    Swiss Med Wkly; 2019 Jun; 149():w20087. PubMed ID: 31256416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast enhanced ultrasound for the diagnosis of liver hemangiomas in clinical practice.
    Sirli R; Sporea I; Popescu A; Dănilă M; Martie A; Bota S; Jurchis A; Sendroiu M
    Med Ultrason; 2011 Jun; 13(2):95-101. PubMed ID: 21655534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice.
    Jacob J; Deganello A; Sellars ME; Hadzic N; Sidhu PS
    Ultraschall Med; 2013 Dec; 34(6):529-40. PubMed ID: 24132647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: First results.
    Jung EM; Ross CJ; Rennert J; Scherer MN; Farkas S; von Breitenbuch P; Schnitzbauer AA; Piso P; Lamby P; Menzel C; Schreyer AG; Feuerbach S; Schlitt HJ; Loss M
    Clin Hemorheol Microcirc; 2010; 46(2-3):89-99. PubMed ID: 21135485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels.
    D'Onofrio M; Faccioli N; Zamboni G; Malagò R; Caffarri S; Fattovich G; Mucelli RP
    Radiol Med; 2008 Oct; 113(7):978-91. PubMed ID: 18779929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
    Strobel D; Jung EM; Ziesch M; Praktiknjo M; Link A; Dietrich CF; Klinger C; Schultheiß M; Jesper D; Schellhaas B
    Eur Radiol; 2021 Oct; 31(10):7614-7625. PubMed ID: 33855588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic performance of contrast-enhanced ultrasound (CEUS) for evaluating hepatocellular carcinoma (HCC) juxtaposed to MRI findings; a retrospective single-center analysis of 292 patients.
    Schwarze V; Marschner C; Völckers W; de Figueiredo GN; Rübenthaler J; Clevert DA
    Clin Hemorheol Microcirc; 2020; 76(2):155-160. PubMed ID: 32925017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing.
    Bleuzen A; Huang C; Olar M; Tchuenbou J; Tranquart F
    Ultraschall Med; 2006 Feb; 27(1):40-8. PubMed ID: 16470478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of contrast-enhanced ultrasound versus computed tomography for hepatocellular carcinoma: a retrospective, single-center evaluation of 234 patients.
    Schwarze V; Marschner C; Völckers W; Grosu S; Negrão de Figueiredo G; Rübenthaler J; Clevert DA
    J Int Med Res; 2020 Jun; 48(6):300060520930151. PubMed ID: 32529869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrast enhanced ultrasound for the diagnosis of liver hemangiomas - results of a Romanian multicentre study.
    Sirli R; Sporea I; Săndulescu DL; Popescu A; Dănilă M; Săftoiu A; Spârchez Z; Badea R
    Med Ultrason; 2015 Dec; 17(4):444-50. PubMed ID: 26649337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablation.
    Wang Y; Jing X; Ding J
    Clin Imaging; 2016; 40(3):402-6. PubMed ID: 27133676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic endoluminal contrast enhanced ultrasound (CEUS) for display of drainages in inflammatory abdominal fluid collections1.
    Jung EM; Jung F; Stroszczynski C; Wiesinger I
    Clin Hemorheol Microcirc; 2022; 80(2):49-59. PubMed ID: 35001884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
    Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
    Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and characterization of focal liver lesions with contrast-enhanced ultrasonography in patients with hepatitis C-induced liver cirrhosis.
    Rahbin N; Siösteen AK; Elvin A; Blomqvist L; Hagen K; Hultcrantz R; Aleman S
    Acta Radiol; 2008 Apr; 49(3):251-7. PubMed ID: 18365808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative Treatment.
    Liu LF; Ding ZL; Zhong JH; Li HX; Liu JJ; Li H; Li LQ
    Biomed Res Int; 2018; 2018():8910562. PubMed ID: 30533441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma < or =2 cm.
    Xu HX; Xie XY; Lu MD; Liu GJ; Xu ZF; Zheng YL; Liang JY; Chen LD
    J Clin Ultrasound; 2008 Jun; 36(5):257-66. PubMed ID: 18088056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of Contrast-Enhanced Sonography Versus MRI With a Liver-Specific Contrast Agent for Diagnosis of Hepatocellular Adenoma and Focal Nodular Hyperplasia.
    Bröker MEE; Taimr P; de Vries M; Braun LMM; de Man RA; Ijzermans JNM; Dwarkasing RS
    AJR Am J Roentgenol; 2020 Jan; 214(1):81-89. PubMed ID: 31573852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.